These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35078654)

  • 21. Stroke and Systemic Embolism and Other Adverse Outcomes of Heart Failure With Preserved and Reduced Ejection Fraction in Patients With Atrial Fibrillation (from the COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation [CODE-AF]).
    Chung S; Kim TH; Uhm JS; Cha MJ; Lee JM; Park J; Park JK; Kang KW; Kim J; Park HW; Choi EK; Kim JB; Kim CS; Lee YS; Shim J; Joung B
    Am J Cardiol; 2020 Jan; 125(1):68-75. PubMed ID: 31699363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation.
    Pandey A; Kim S; Moore C; Thomas L; Gersh B; Allen LA; Kowey PR; Mahaffey KW; Hylek E; Peterson ED; Piccini JP; Fonarow GC;
    JACC Heart Fail; 2017 Jan; 5(1):44-52. PubMed ID: 28034376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of atrial fibrillation in acute decompensated heart failure with reduced versus preserved ejection fraction.
    Jobs A; Schwind J; Katalinic A; Babaev V; Tilz RR; Rausch S; Thiele H; Eitel I; Eitel C
    Clin Res Cardiol; 2019 Jan; 108(1):74-82. PubMed ID: 29987595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial resynchronization therapy in patients with atrial fibrillation and heart failure with and without systolic left ventricular dysfunction: a pilot study.
    Saksena S; Slee A; Saad M
    J Interv Card Electrophysiol; 2018 Oct; 53(1):9-17. PubMed ID: 29987682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry.
    Zafrir B; Lund LH; Laroche C; Ruschitzka F; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Seferovic PM; Maggioni AP; De Mora Martin M; Polonski L; Silva-Cardoso J; Amir O;
    Eur Heart J; 2018 Dec; 39(48):4277-4284. PubMed ID: 30325423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes.
    Kotecha D; Chudasama R; Lane DA; Kirchhof P; Lip GY
    Int J Cardiol; 2016 Jan; 203():660-6. PubMed ID: 26580351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart rate and outcome in heart failure with reduced ejection fraction: Differences between atrial fibrillation and sinus rhythm-A CIBIS II analysis.
    Mulder BA; Damman K; Van Veldhuisen DJ; Van Gelder IC; Rienstra M
    Clin Cardiol; 2017 Sep; 40(9):740-745. PubMed ID: 28513877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation.
    Duarte R; Stainthorpe A; Greenhalgh J; Richardson M; Nevitt S; Mahon J; Kotas E; Boland A; Thom H; Marshall T; Hall M; Takwoingi Y
    Health Technol Assess; 2020 Jan; 24(3):1-164. PubMed ID: 31933471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction.
    Attia ZI; Noseworthy PA; Lopez-Jimenez F; Asirvatham SJ; Deshmukh AJ; Gersh BJ; Carter RE; Yao X; Rabinstein AA; Erickson BJ; Kapa S; Friedman PA
    Lancet; 2019 Sep; 394(10201):861-867. PubMed ID: 31378392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating microRNA-1a is a biomarker of Graves' disease patients with atrial fibrillation.
    Wang F; Zhang SJ; Yao X; Tian DM; Zhang KQ; She DM; Guo FF; Zhai QW; Ying H; Xue Y
    Endocrine; 2017 Jul; 57(1):125-137. PubMed ID: 28547036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients.
    Wu Y; Xie Z; Liang W; Xue R; Wu Z; Wu D; He J; Zhu W; Liu C
    ESC Heart Fail; 2021 Apr; 8(2):1369-1377. PubMed ID: 33506643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.
    Vermond RA; Geelhoed B; Verweij N; Tieleman RG; Van der Harst P; Hillege HL; Van Gilst WH; Van Gelder IC; Rienstra M
    J Am Coll Cardiol; 2015 Sep; 66(9):1000-7. PubMed ID: 26314526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.
    Black-Maier E; Ren X; Steinberg BA; Green CL; Barnett AS; Rosa NS; Al-Khatib SM; Atwater BD; Daubert JP; Frazier-Mills C; Grant AO; Hegland DD; Jackson KP; Jackson LR; Koontz JI; Lewis RK; Sun AY; Thomas KL; Bahnson TD; Piccini JP
    Heart Rhythm; 2018 May; 15(5):651-657. PubMed ID: 29222043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy.
    Siller-Matula JM; Pecen L; Patti G; Lucerna M; Kirchhof P; Lesiak M; Huber K; Verheugt FWA; Lang IM; Renda G; Schnabel RB; Wachter R; Kotecha D; Sellal JM; Rohla M; Ricci F; De Caterina R;
    Int J Cardiol; 2018 Aug; 265():141-147. PubMed ID: 29706429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial fibrillation is not an independent predictor of outcome in patients with aortic stenosis.
    Zhang H; El-Am EA; Thaden JJ; Pislaru SV; Scott CG; Krittanawong C; Chahal AA; Breen TJ; Eleid MF; Melduni RM; Greason KL; McCully RB; Enriquez-Sarano M; Oh JK; Pellikka PA; Nkomo VT
    Heart; 2020 Feb; 106(4):280-286. PubMed ID: 31439661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial flutter: Clinical risk factors and adverse outcomes in the Framingham Heart Study.
    Rahman F; Wang N; Yin X; Ellinor PT; Lubitz SA; LeLorier PA; McManus DD; Sullivan LM; Seshadri S; Vasan RS; Benjamin EJ; Magnani JW
    Heart Rhythm; 2016 Jan; 13(1):233-40. PubMed ID: 26226213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation.
    Ahn MS; Yoo BS; Son JW; Yu MH; Kang DR; Lee HY; Jeon ES; Kim JJ; Chae SC; Baek SH; Kang SM; Choi DJ; Kim KH; Cho MC; Kim SY
    J Korean Med Sci; 2020 Aug; 35(33):e278. PubMed ID: 32830467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial fibrillation and heart failure with preserved ejection fraction: Insights on a unique clinical phenotype from a nationally-representative United States cohort.
    Goyal P; Almarzooq ZI; Cheung J; Kamel H; Krishnan U; Feldman DN; Horn EM; Kim LK
    Int J Cardiol; 2018 Sep; 266():112-118. PubMed ID: 29887426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethnic differences in atrial fibrillation among patients with heart failure in Asia.
    Tan ESJ; Goh V; Santema BT; Tay WT; Teng TK; Yap J; Tromp J; Hung CL; Chopra V; Anand I; MacDonald MR; Ling LH; ; Van Gelder IC; Rienstra M; Voors AA; Richards AM; Lam CSP
    ESC Heart Fail; 2020 Aug; 7(4):1419-1429. PubMed ID: 32383559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.